Key result
Dysfunctional heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and antibodies to hnRNP A1 may play a potential role in the pathogenesis of neurodegeneration and axonal damage in multiple sclerosis.
This review highlights the potential role of dysfunctional hnRNP A1 and its antibodies in driving neurodegeneration and permanent disability in multiple sclerosis.
Multiple sclerosis (MS) is a demyelinating, autoimmune disease of the central nervous system. In recent years, it has become more evident that neurodegeneration, including neuronal damage and axonal injury, underlies permanent disability in MS. This manuscript reviews some of the mechanisms that could be responsible for neurodegeneration and axonal damage in MS and highlights the potential role that dysfunctional heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and antibodies to hnRNP A1 may play in MS pathogenesis.
No takes yet. Share an insight, caveat, or question.
Salapa et al. (2017) conducted a review in Multiple sclerosis. Dysfunctional hnRNP A1 and antibodies to hnRNP A1 was evaluated. Dysfunctional heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and antibodies to hnRNP A1 may play a potential role in the pathogenesis of neurodegeneration and axonal damage in multiple sclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: